Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Kindt

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Life Sciences|April 21, 1986
Prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic toxicity in mice by MDL 72145, a selective inhibitor of MAO-BM V Kindt, R E Heikkila
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1987
Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridineM V Kindt, R E Heikkila, W J Nicklas
Journal of Neurochemistry|October 1, 1986
Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transportR A Mayer, M V Kindt, R E Heikkila
Digestive Diseases and Sciences|May 20, 1998
Comparative study of potential for bisphosphonates to damage gastric mucosa of ratsC P Peter, M V Kindt, J A Majka
Life Sciences|February 23, 1987
MPTP, MPP+ and mitochondrial functionW J Nicklas, S K Youngster, M V Kindt, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1987
Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouseP K Sonsalla, S K Youngster, M V Kindt, et al.
Life Sciences|January 1, 1988
Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in miceR W Fuller, S K Hemrick-Luecke, M V Kindt, et al.
Transplantation Proceedings|January 5, 2000
Tacrolimus toxicity in rhesus monkey: model for clinical side effectsM V Kindt, R Kemp, H L Allen, et al.
European Journal of Pharmacology|February 9, 1988
Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTPM V Kindt, S K Youngster, P K Sonsalla, et al.
European Journal of Pharmacology|March 18, 1986
1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-CH3-MPTP) is a more potent dopaminergic neurotoxin than MPTP in miceS K Youngster, R C Duvoisin, A Hess, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Life Sciences|April 21, 1986
Prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic toxicity in mice by MDL 72145, a selective inhibitor of MAO-BM V Kindt, R E Heikkila
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1987
Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridineM V Kindt, R E Heikkila, W J Nicklas
Journal of Neurochemistry|October 1, 1986
Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transportR A Mayer, M V Kindt, R E Heikkila
Digestive Diseases and Sciences|May 20, 1998
Comparative study of potential for bisphosphonates to damage gastric mucosa of ratsC P Peter, M V Kindt, J A Majka
Life Sciences|February 23, 1987
MPTP, MPP+ and mitochondrial functionW J Nicklas, S K Youngster, M V Kindt, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1987
Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouseP K Sonsalla, S K Youngster, M V Kindt, et al.
Life Sciences|January 1, 1988
Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in miceR W Fuller, S K Hemrick-Luecke, M V Kindt, et al.
Transplantation Proceedings|January 5, 2000
Tacrolimus toxicity in rhesus monkey: model for clinical side effectsM V Kindt, R Kemp, H L Allen, et al.
European Journal of Pharmacology|February 9, 1988
Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTPM V Kindt, S K Youngster, P K Sonsalla, et al.
European Journal of Pharmacology|March 18, 1986
1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-CH3-MPTP) is a more potent dopaminergic neurotoxin than MPTP in miceS K Youngster, R C Duvoisin, A Hess, et al.
Pageof 2